159 related articles for article (PubMed ID: 37799074)
1. Identification of key immune cell-related genes involved in tumorigenesis and prognosis of cervical squamous cell carcinoma.
Yan C; Ma Y; Li J; Chen X; Ma J
Hum Vaccin Immunother; 2023 Aug; 19(2):2254239. PubMed ID: 37799074
[TBL] [Abstract][Full Text] [Related]
2. Identification of cervical squamous cell carcinoma feature genes and construction of a prognostic model based on immune-related features.
He C; Ren L; Yuan M; Liu M; Liu K; Qian X; Lu J
BMC Womens Health; 2022 Sep; 22(1):365. PubMed ID: 36057587
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Molecule PLA2G2D Is a Potential Prognostic Biomarker Correlating With Immune Cell Infiltration and the Expression of Immune Checkpoint Genes in Cervical Squamous Cell Carcinoma.
Liu H; Xu R; Gao C; Zhu T; Liu L; Yang Y; Zeng H; Huang Y; Wang H
Front Oncol; 2021; 11():755668. PubMed ID: 34733790
[TBL] [Abstract][Full Text] [Related]
4. Prognostic genes in the tumor microenvironment in cervical squamous cell carcinoma.
Pan XB; Lu Y; Huang JL; Long Y; Yao DS
Aging (Albany NY); 2019 Nov; 11(22):10154-10166. PubMed ID: 31740624
[TBL] [Abstract][Full Text] [Related]
5. Correlation between reticulum ribosome-binding protein 1 (RRBP1) overexpression and prognosis in cervical squamous cell carcinoma.
Zhu J; Zhao R; Xu W; Ma J; Ning X; Ma R; Meng F
Biosci Trends; 2020 Sep; 14(4):279-284. PubMed ID: 32536673
[TBL] [Abstract][Full Text] [Related]
6. Immune landscape and heterogeneity of cervical squamous cell carcinoma and adenocarcinoma.
Liu B; Xu Y; Hu B; Song X; Lin S; Wang J; Wang L; Chu T; Peng T; Xu M; Ding W; Cao C; Wu P; Li L
Aging (Albany NY); 2024 Jan; 16(1):568-592. PubMed ID: 38206304
[TBL] [Abstract][Full Text] [Related]
7. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC.
Ding Y; Chu L; Cao Q; Lei H; Li X; Zhuang Q
BMC Cancer; 2023 Jan; 23(1):45. PubMed ID: 36639648
[TBL] [Abstract][Full Text] [Related]
8. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
[TBL] [Abstract][Full Text] [Related]
9. Potential biomarkers for the prognosis and treatment of HCC immunotherapy.
Li H; He Q; Zhou GM; Wang WJ; Shi PP; Wang ZH
Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2027-2046. PubMed ID: 36930502
[TBL] [Abstract][Full Text] [Related]
10. Acylglycerol kinase is over-expressed in early-stage cervical squamous cell cancer and predicts poor prognosis.
Sun F; Xiong Y; Zhou XH; Li Q; Xiao L; Long P; Li LJ; Cai MY; Wei YX; Ma YL; Yu YH
Tumour Biol; 2016 May; 37(5):6729-36. PubMed ID: 26662108
[TBL] [Abstract][Full Text] [Related]
11. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
Luo Y; Liu H; Fu H; Ding GS; Teng F
Front Immunol; 2022; 13():974377. PubMed ID: 36458010
[TBL] [Abstract][Full Text] [Related]
12. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
13. LncRNA NEF inhibits migration and invasion of HPV-negative cervical squamous cell carcinoma by inhibiting TGF-β pathway.
Ju W; Luo X; Zhang N
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30910843
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the microRNA profile in early-stage cervical squamous cell carcinoma by next-generation sequencing.
Lin W; Feng M; Chen G; Zhou Z; Li J; Ye Y
Oncol Rep; 2017 Mar; 37(3):1477-1486. PubMed ID: 28098890
[TBL] [Abstract][Full Text] [Related]
15. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y
Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188
[No Abstract] [Full Text] [Related]
16. RGS1 and related genes as potential targets for immunotherapy in cervical cancer: computational biology and experimental validation.
Zhang S; Wang H; Liu J; Tao T; Zeng Z; Wang M
J Transl Med; 2022 Jul; 20(1):334. PubMed ID: 35879796
[TBL] [Abstract][Full Text] [Related]
17. Multiple datasets to explore the tumor microenvironment of cutaneous squamous cell carcinoma.
Xing J; Chen M; Han Y
Math Biosci Eng; 2022 Apr; 19(6):5905-5924. PubMed ID: 35603384
[TBL] [Abstract][Full Text] [Related]
18. Single-Nucleus RNA Sequencing and Spatial Transcriptomics Reveal the Immunological Microenvironment of Cervical Squamous Cell Carcinoma.
Ou Z; Lin S; Qiu J; Ding W; Ren P; Chen D; Wang J; Tong Y; Wu D; Chen A; Deng Y; Cheng M; Peng T; Lu H; Yang H; Wang J; Jin X; Ma D; Xu X; Wang Y; Li J; Wu P
Adv Sci (Weinh); 2022 Oct; 9(29):e2203040. PubMed ID: 35986392
[TBL] [Abstract][Full Text] [Related]
19. Identification of ferroptosis-related molecular subtypes and a methylation-related ferroptosis gene prognostic signature in cervical squamous cell carcinoma.
Yu L; Gao Z; Li Z; Liu P; Gao Y; Liang G
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14673-14689. PubMed ID: 37584713
[TBL] [Abstract][Full Text] [Related]
20. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G
Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
